The state of Maryland and the Anne Arundel County Economic Development Corp. (AAEDC) announced today their support of Paragon Bioservices' new commercial manufacturing facility under development in Anne Arundel County and the addition of 200 new jobs over the next four years.

Earlier this year, Paragon, a leading biologics contract development and manufacturing organization (CDMO) with expertise in gene therapy and next-generation vaccines, announced plans to lease 150,000 square feet in the BW Gateway development on Harmans Road.

The new facility will enable the company to expand its manufacturing operations, as well as house some of its administrative and business development activities which will move from the University of Maryland BioPark. The company is planning to retain its Baltimore City operations in the BioPark, as well as its 200 employees at that location.

"The expansion of our biopharmaceutical manufacturing capabilities via our new site, including the ability for commercial manufacturing, is a key strategic initiative for Paragon," said Pete Buzy, Paragon's president and CEO.

READ MORE.